<?xml version="1.0" encoding="UTF-8"?><marc:collection xmlns:marc="http://www.loc.gov/MARC21/slim">
  <marc:record>
    <marc:leader>00000nam  2200000zi 4500</marc:leader>
    <marc:controlfield tag="001">9.954009</marc:controlfield>
    <marc:controlfield tag="003">CaOODSP</marc:controlfield>
    <marc:controlfield tag="005">20250822151545</marc:controlfield>
    <marc:controlfield tag="006">m     o  d f      </marc:controlfield>
    <marc:controlfield tag="007">cr cn ||||||||</marc:controlfield>
    <marc:controlfield tag="008">250812s2024    oncd    os   f000 0 eng d</marc:controlfield>
    <marc:datafield tag="040" ind1=" " ind2=" ">
      <marc:subfield code="a">CaOODSP</marc:subfield>
      <marc:subfield code="b">eng</marc:subfield>
      <marc:subfield code="e">rda</marc:subfield>
      <marc:subfield code="c">CaOODSP</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="041" ind1="0" ind2=" ">
      <marc:subfield code="a">eng</marc:subfield>
      <marc:subfield code="a">fre</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="043" ind1=" " ind2=" ">
      <marc:subfield code="a">n-cn---</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="086" ind1="1" ind2=" ">
      <marc:subfield code="a">H82-58/2024-PDF</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="100" ind1="1" ind2=" ">
      <marc:subfield code="a">Gaudette, Étienne, </marc:subfield>
      <marc:subfield code="d">1953- </marc:subfield>
      <marc:subfield code="e">author.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="245" ind1="1" ind2="0">
      <marc:subfield code="a">Cost-effectiveness of the top 100 drugs by public spending in Canada, 2015–2021 : </marc:subfield>
      <marc:subfield code="b">a repeated cross-sectional study / </marc:subfield>
      <marc:subfield code="c">Étienne Gaudette, Shirin Rizzardo, Yvonne Zhang, Mina Tadrous, and Kevin R. Pothier = Rapport coût-efficacité des 100 médicaments représentant les plus grandes dépenses des régimes publics au Canada, 2015-2021 : une étude transversale répétée / Étienne Gaudette, Shirin Rizzardo, Yvonne Zhang, Mina Tadrous et Kevin R. Pothier.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="246" ind1="1" ind2="1">
      <marc:subfield code="a">Rapport coût-efficacité des 100 médicaments représentant les plus grandes dépenses des régimes publics au Canada, 2015-2021 : </marc:subfield>
      <marc:subfield code="b">une étude transversale répétée</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="264" ind1=" " ind2="1">
      <marc:subfield code="a">[Ottawa] : </marc:subfield>
      <marc:subfield code="b">Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, </marc:subfield>
      <marc:subfield code="c">[2024]</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="300" ind1=" " ind2=" ">
      <marc:subfield code="a">1 online resource (1 unnumbered page) : </marc:subfield>
      <marc:subfield code="b">graphs</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="336" ind1=" " ind2=" ">
      <marc:subfield code="a">text</marc:subfield>
      <marc:subfield code="b">txt</marc:subfield>
      <marc:subfield code="2">rdacontent</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="337" ind1=" " ind2=" ">
      <marc:subfield code="a">computer</marc:subfield>
      <marc:subfield code="b">c</marc:subfield>
      <marc:subfield code="2">rdamedia</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="338" ind1=" " ind2=" ">
      <marc:subfield code="a">online resource</marc:subfield>
      <marc:subfield code="b">cr</marc:subfield>
      <marc:subfield code="2">rdacarrier</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">Caption title.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="500" ind1=" " ind2=" ">
      <marc:subfield code="a">"NPDUIS, National Prescription Drug Utilization Information System, "Supporting health care decision making in Canada" = SNIUMP, Le Système national d'information sur l'utilisation des médicaments prescrits, « Appuyer les décisions en matière des soins de santé au Canada »"</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="520" ind1=" " ind2=" ">
      <marc:subfield code="a">"To assess the distribution and spending by cost-effectiveness category amongst those drugs with the highest public spending levels in Canada. The share of public pharmaceutical spending allocated to cost-effective and cost-ineffective drugs was estimated using Canadian Agency for Drugs and Technologies in Health (CADTH) cost-effectiveness assessments and Canadian public plan spending data from six provinces"--Introduction, page [1].</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="546" ind1=" " ind2=" ">
      <marc:subfield code="a">Text in English and French.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="0">
      <marc:subfield code="a">Drugs</marc:subfield>
      <marc:subfield code="z">Canada</marc:subfield>
      <marc:subfield code="v">Statistics.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="0">
      <marc:subfield code="a">Pharmaceutical policy</marc:subfield>
      <marc:subfield code="z">Canada</marc:subfield>
      <marc:subfield code="v">Statistics.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="650" ind1=" " ind2="0">
      <marc:subfield code="a">Expenditures, Public</marc:subfield>
      <marc:subfield code="v">Statistics.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="651" ind1=" " ind2="0">
      <marc:subfield code="a">Canada</marc:subfield>
      <marc:subfield code="x">Appropriations and expenditures</marc:subfield>
      <marc:subfield code="v">Statistics.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="655" ind1=" " ind2="7">
      <marc:subfield code="a">Statistics</marc:subfield>
      <marc:subfield code="2">lcgft</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="710" ind1="1" ind2=" ">
      <marc:subfield code="a">Canada. </marc:subfield>
      <marc:subfield code="b">Patented Medicine Prices Review Board, </marc:subfield>
      <marc:subfield code="e">issuing body.</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="788" ind1=" " ind2=" ">
      <marc:subfield code="t">Cost-effectiveness of the top 100 drugs by public spending in Canada, 2015–2021 : </marc:subfield>
      <marc:subfield code="e">fre</marc:subfield>
      <marc:subfield code="w">(CaOODSP)9.954008</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2="0">
      <marc:subfield code="q">PDF</marc:subfield>
      <marc:subfield code="s">441 KB</marc:subfield>
      <marc:subfield code="u">https://publications.gc.ca/collections/collection_2025/cepmb-pmprb/H82-58-2024.pdf</marc:subfield>
    </marc:datafield>
    <marc:datafield tag="856" ind1="4" ind2=" ">
      <marc:subfield code="q">HTML</marc:subfield>
      <marc:subfield code="s">N/A</marc:subfield>
      <marc:subfield code="u">https://www.canada.ca/en/patented-medicine-prices-review/services/npduis/analytical-studies/posters/cost-effectiveness-100-drugs.html</marc:subfield>
    </marc:datafield>
  </marc:record>
</marc:collection>
